Antithyroid Medications for Graves' Disease

被引:0
|
作者
Brown, Charles H. [1 ]
机构
[1] Purdue Univ, Coll Pharm, Clin Pharm, W Lafayette, IN 47907 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Graves' disease is an autoimmune disorder that occurs when the immune system attacks the thyroid gland and causes it to produce too much thyroid hormone (hyperthyroidism). The exact cause of Graves' disease is not known. The disorder can affect anyone at any age, but it is more common in women. If left untreated, Graves' disease can cause a severe, life-threatening crisis (i.e., thyroid storm). The primary goals of treatment are to eliminate excess thyroid hormone and minimize the long-term consequences of the disease. Treatments include radioactive iodine, antithyroid medications (propylthiouracil, methimazole), and surgery. Beta-blockers may be used to provide symptomatic relief.
引用
收藏
页码:HS14 / HS18
页数:5
相关论文
共 50 条
  • [31] ANTITHYROID DRUGS AND GRAVES-DISEASE, OR THE CHOICE OF A THERAPEUTIC STRATEGY
    ALLANNIC, H
    LORCY, Y
    LEGUERRIER, AM
    DELAMBRE, C
    STETIEH, H
    MADEC, AM
    ORGIAZZI, J
    PRESSE MEDICALE, 1991, 20 (14): : 645 - 651
  • [32] ANTITHYROID DRUG-TREATMENT IN THE MANAGEMENT OF GRAVES-DISEASE
    YOUNG, R
    JONES, S
    HEDLEY, A
    CLINICAL SCIENCE, 1982, 63 (03) : P27 - P27
  • [33] Optimizing remission rates using antithyroid drugs for Graves' disease
    Hegedus, Laszlo
    CLINICAL ENDOCRINOLOGY, 2010, 72 (06) : 729 - 730
  • [34] Antithyroid arthritis syndrome caused by methimazole in a patient with Graves' disease
    Kawasumi, Muneo
    Kubota, Mitsunobu
    Yoshii, Yoko
    Tokunaga, Tadahiro
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2023, 2023 (03): : 1 - 5
  • [35] INCIDENCE OF REMISSION AFTER ANTITHYROID DRUG TREATMENT IN GRAVES DISEASE
    WILS, JA
    KLOPPENB.PW
    ACTA ENDOCRINOLOGICA, 1969, S : 173 - &
  • [36] STRATEGY FOR ANTITHYROID DRUG-THERAPY IN GRAVES-DISEASE
    ALLANNIC, H
    HORMONE RESEARCH, 1987, 26 (1-4) : 146 - 153
  • [37] Preoperative plasmapheresis in patients with Graves' disease intolerant to antithyroid drugs
    Apaydin, Tugce
    Gogas Yavuz, Dilek
    THERAPEUTIC APHERESIS AND DIALYSIS, 2021, 25 (06) : 877 - 883
  • [38] Long-Term Antithyroid Treatment in Pediatric and Juvenile Graves' Disease
    Delshad, Hossein
    Takyar, Miralireza
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 18
  • [39] Thyroglobulin Autoantibodies Are Associated with Refractoriness to Antithyroid Drug Treatment for Graves' Disease
    Katahira, Masahito
    Ogata, Hidetada
    INTERNAL MEDICINE, 2016, 55 (12) : 1519 - 1524
  • [40] SUPPRESSIBILITY OF THYROID FUNCTION DURING TREATMENT WITH ANTITHYROID DRUGS IN GRAVES DISEASE
    WILS, JA
    KLOPPENBORG, PW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 30 (03): : 406 - +